Harnessing Europe’s Data Potential: How HONEUR Can Help Improve Patient Outcomes

Article sponsored by Johnson & Johnson

Bridging research and clinical practice with RWE

Real-world data (RWD) is one of Europe’s most powerful yet underused healthcare assets. When robustly collected and analysed to generate real-world evidence (RWE), it can inform evidence-based decision-making, improve efficiency, accelerate innovation, and catalyse transformation across the healthcare ecosystem – helping health systems maximise the value of health for patients and society.

RWE complements clinical trials by revealing how treatments perform in diverse real-world settings. It helps generate deeper insights into patient experience and outcomes in routine care, ensuring healthcare professionals remain partners in translating patient data into meaningful healthcare improvement.

Europe should seize the momentum. With the right frameworks, infrastructure and investment, the region can enable RWE to power a truly self-learning health system – one that continuously adapts,…